Presentations

Filter per year

20Sep

2024

Investor Science Call from ECTRIMS

Friday, September 20, 2024 from 16:00 CEST / 10:00am EDT / 07:00 am PDT

16:00 CEST

Investor Presentation

Discover more

7Dec

2023

R&D Day

Sanofi was pleased to host investors and analysts for its R&D Day held in person at the Kimpton Hotel Eventi in New York City on Thursday, December 7, 2023.

08:30 EST

Investor Presentation

Discover more

29Jun

2023

Vaccines Investor Event

Sanofi was pleased to host investors and analysts for its Vaccines Investor Event held in person on June 29th, 2023

15:00 - 18:00

Investor Presentation

Discover more

22May

2023

ATS Investor Call

Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)

18:00 - 19:30

Investor Presentation

Discover more

13Jul

2022

Hemophilia Investor Event

Sanofi was pleased to host investors and analysts for its Hemophilia Investor Event held in person at ExCel London on Wednesday, July 13, 2022. (2:00pm GMT / 15h00 CET / 9:00am EST)

15:00 - 17:00

Investor Presentation

Discover more

5Jul

2022

ESG Investor Event

Sanofi was pleased to invite investors and analysts to participate in its ESG Investor Event held in-person at the Sanofi Headquarters (54, rue La Boétie, 75008 Paris) on Tuesday, July 5, 2022. (14:00h CET / 8:00am EST)

14:00 - 16:00

Investor Presentation

Discover more

18May

2022

Accounting call

09:00 - 17:00

Investor Presentation

Discover more

1Apr

2022

EUROAPI Capital Markets Day

09:00 - 17:00

Investor Presentation

Discover more

29Mar

2022

Immunology Investor Event

Sanofi was pleased to host investors and analysts for its Immunology Investor Event held in person in our new Sanofi Cambridge Headquarters in Cambridge, Massachusetts. (16h00 CET / 10:00am EST)

16:00 - 18:00

Investor Presentation

Discover more

25Feb

2022

ACTRIMS Investor Call

Sanofi was pleased to invite investors and analysts to participate in a live webcast discussing tolebrutinib data presented during the ACTRIMS scientific program (February 24-26, 2022). (16h00 CET / 10:00am EST)

16:00 - 18:00

Investor Presentation

Discover more